申请人:Andersen Knud Erik
公开号:US20110009420A1
公开(公告)日:2011-01-13
The present invention provides compounds of the formula
wherein R
1
, R
2
and B are as herein described, pharmaceutical compositions comprising these compounds, use of these compounds for the preparation of pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of disorders and diseases wherein modulation of the H
3
receptor is beneficial.
本发明提供了以下式子的化合物,其中R1、R2和B的定义如下,还提供了包含这些化合物的药物组合物,使用这些化合物制备药物组合物的方法以及使用这些化合物治疗和/或预防调节H3受体有益的疾病和疾病的方法。